On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...
The global cell and gene therapy market is undergoing rapid expansion, driven by the surge in regulatory approvals and continual advancements in therapeutic technologies. The market is anticipated to ...
Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...
St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.
A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...
It is not only a time of prime apple picking and pumpkin spice drinking but also something much more exciting for scientists ...
Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, ...
Currently, organoids and spheroids market growth is fueled by regulatory support for non-animal models and heavy investment ...
Voss and his team have used CRISPR gene-editing to reprogram human B cells to produce antibodies that can recognize and block many different strains of HIV. And although existing humanized mouse ...
Sometimes, it takes a lot of work to find the best rom-coms on Amazon Prime Video, especially since the streamer doesn’t usually put the great ones on top. The good news is that October’s lineup ...
Halloween is just around the corner, but you wouldn’t know it by looking at Prime Video’s 10 most popular movies and shows chart. Near the top of the chart is the romantic drama Culpa Nuestra, the ...
Advances in genome editing are transforming the treatment for rare genetic diseases, as seen in the case of seven-month-old ...